NORDIC PHARMACEUTICALS ApS: Financial statements 2014
CVR: 27430015
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 898,701 and a net result of DKK 151,604 compared with DKK 189,528 the year before. That is an increase of 11.2% compared with the year before. Equity in the 2014 report amounted to DKK 762,229. The solvency ratio was 32.9%.
- Gross Profit
- DKK 898,701
- Profit/Loss
- DKK 151,604
- Equity
- DKK 762,229
- Total Assets
- DKK 2,320,031
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 899 t. | 152 t. | 762 t. | - |
| 2013 | - | 808 t. | 190 t. | 611 t. | - |
| 2012 | - | 959 t. | 421 t. | 614 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
NORDIC PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 808,383, and the net result was DKK 189,528.
As of June 11, 2014, ONE REVISION A/S has been appointed auditor of NORDIC PHARMACEUTICALS ApS.
As of June 11, 2014, inforevision statsautoriseret revisionsaktieselskab has stepped down as auditor of NORDIC PHARMACEUTICALS ApS.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.